Evidence map›Paper›PMID 28523532›Full record

ArticleNeurochemical research2017

Progressive Pathological Changes in Neurochemical Profile of the Hippocampus and Early Changes in the Olfactory Bulbs of Tau Transgenic Mice (rTg4510).

Jieun Kim, In-Young Choi, Karen E Duff, Phil Lee

Abstract read
In one paragraph

Article in Neurochemical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Neurobiology of aging · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Magnetic Resonance Imaging in Tauopathy Animal Models.Frontiers in aging neuroscience · 2021
    Review
  10. Frontal lobeNeurology · 2019
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jieun KimHoglund Brain Imaging Center, University of Kansas Medical Center, 3901 Rainbow Blvd, Mail Stop 1052, Kansas City, KS, 66160, USA.
In-Young ChoiHoglund Brain Imaging Center, University of Kansas Medical Center, 3901 Rainbow Blvd, Mail Stop 1052, Kansas City, KS, 66160, USA.
Karen E DuffDepartment of Integrative Neuroscience, Columbia University Medical Center, New York, NY, 10032, USA.
Phil LeeHoglund Brain Imaging Center, University of Kansas Medical Center, 3901 Rainbow Blvd, Mail Stop 1052, Kansas City, KS, 66160, USA. plee2@kumc.edu.ORCID http://orcid.org/0000-0002-2087-8887
University of Kansas Medical Center · USColumbia University Irving Medical Center · US

Funding

Research Design and Analysis Core (RDAC)P30HD002528 · NICHD · UNIVERSITY OF KANSAS LAWRENCE · PI FOWLER, STEPHEN CLETIUS · 1985 to 2015
$22.1M
University of Kansas Alzheimer's Disease Core CentersP30AG035982 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SWERDLOW, RUSSELL H. · 2011 to 2020
$16.6M
NIA NIH HHS P30 AG035982NICHD NIH HHS P30 HD002528
6 · The paper itself

Abstract

Tauopathies such as Alzheimer's disease and frontotemporal lobe degeneration (FTLD-tau) dementia, characterized by pathologic aggregation of the microtubule-associated tau protein and formation of neurofibrillary tangles, have been linked to neurodegeneration and cognitive decline. The early detection of cerebral abnormalities and the identification of biological contributors to the continuous pathologic processes of neurodegeneration in tauopathies critically hinge on sensitive and reliable measures of biomarkers in the living brain. In this study, we measured alterations in a number of key neurochemicals associated with tauopathy-induced neurodegeneration in the hippocampus and the olfactory bulbs of a transgenic mouse model of FTLD-tauopathy, line rTg4510, using in vivo

Indexed as

Disease ProgressionAnimalsAtrophyFrontotemporal DementiaHippocampusHumansMiceMice, TransgenicOlfactory BulbOrgan SizeTauopathiestau ProteinsMAPT protein, humantau ProteinsBrain atrophyHippocampusMagnetic resonance imagingMagnetic resonance spectroscopyOlfactory bulbTauopathyTransgenic mouse model, rTg4510

Identifiers

PMID28523532
PMCPMC5565734
OpenAlexW2616673695

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.